Zenivol Longitudinal, RWD Trial in Insomnia Results
Filed with ASX · · 5 pages · English
Zelira Therapeutics Ltd. on 6ix
Story so far
Earlier from Zelira Therapeutics
- Hope 1 Longitudinal, Real-World Data Trial in ASD Results
- March 2022 Quarterly Activities Report
- Appendix 4D & FY22 Interim Financial Report
- ZLD: Zelira to acquire Health House International Limited
- Zelira Therapeutics Ltd to acquire Health House
Later from Zelira Therapeutics
- EDCDM Technology License Agreement Update
- Pause in Trading
- Response to ASX Price Query
- Zenivol receives formal BfArM approval in Germany
- June 2022 Quarterly Activities Report
Follow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics